US House letter to HHS regarding Kalderos and their new program
October 28, 2020
US House letter to HHS regarding Kalderos and their new program called “340B Pay”. 340B Pay will uproot the current 340B cash flow model and
US House letter to HHS regarding Kalderos and their new program called “340B Pay”. 340B Pay will uproot the current 340B cash flow model and
Health Centers Sue HHS over Pharma 340B Pricing for Contract Pharmacy attack.See complaint attached.
RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks. See complaint attached.
AstraZeneca and Sanofi Block Access to 340B Contract Pharmacy Pricing but not Novartis. See the letter from Sanofi attached.